Brevan Howard Capital Management’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.35M Buy
20,654
+19,132
+1,257% +$4.1M 0.03% 391
2026
Q1
$337K Buy
+1,522
New +$372K ﹤0.01% 1550
2024
Q4
Sell
-6,798
Closed -$1.65M 1411
2024
Q3
$1.65M Buy
6,798
+1,456
+27% +$340K 0.01% 314
2024
Q2
$1.17M Buy
+5,342
New +$1.16M 0.01% 328
2024
Q1
Sell
-1,451
Closed -$319K 1335
2023
Q4
$319K Buy
+1,451
New +$307K ﹤0.01% 689

Other funds holding STE

Brevan Howard Capital Management's STE Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Steris (STE) stake by 1,257% in Q2 2026, buying an estimated $4.1M and bringing the position to 20,654 shares worth $4.35M. The position accounts for 0.03% of the portfolio, ranked #391.

Brevan Howard Capital Management first reported a position in STE in Q4 2023 and has held it in 5 quarters since. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Brevan Howard Capital Management held 20,654 shares of Steris worth $4.35M as of Q2 2026.
  • Brevan Howard Capital Management bought 19,132 Steris shares in Q2 2026, an estimated $4.1M.
  • Steris made up 0.03% of Brevan Howard Capital Management's portfolio in Q2 2026, its #391 holding.
  • Brevan Howard Capital Management first reported a position in Steris in Q4 2023 and has held it in 5 quarters since.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.